Ecolab Q1 adj EPS $1.34 (+52%); raises FY guide to $6.40-$6.70; sells surgical unit for $950M

ECOLAB INC.

2024-Q1 EPS reported $1.43 revenue$3,751,900,000

Adjusted diluted EPS $1.34, +52% YoY; reported diluted EPS $1.43, +74%.
Organic sales +5% to $3.72B; organic operating margin +400 bps to 14.7%.
Sale of global surgical solutions to Medline for $950M cash; expected close H2 2024.
FY2024 adjusted EPS guidance raised to $6.40-$6.70, +23-29% versus prior $6.10-$6.50.
Institutional & Specialty organic sales +11%, operating income +90% YoY.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

ECOLAB INC. reported the first quarter ended March 31, 2024 results: revenue $3,751.9, net income $412.1, EPS $1.43. Guidance raised.

Period: the first quarter ended March 31, 2024
Revenue: $3,751.9
Net income: $412.1
EPS: $1.43
Guidance: raised
Result: reported results

Exact text from the filing

Adjusted (unaudited) Public Currency Rates % Public Currency Rates % (millions, except per share) 2024 2023 Change 2024 2023 Change Net sales $3,751.9 $3,571.6 5 % $3,751.9 $3,571.6 5 % Operating income 517.9 351.6 47 % 547.7 379.3 44 % Net income attributable to Ecolab 412.1 233.4

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

ECOLAB INC. filing history →

Source: SEC EDGAR

accession 0001558370-24-006197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.